139 related articles for article (PubMed ID: 18040064)
1. Inflammation and oxidative stress in obstructive sleep apnea syndrome.
Selmi C; Montano N; Furlan R; Keen CL; Gershwin ME
Exp Biol Med (Maywood); 2007 Dec; 232(11):1409-13. PubMed ID: 18040064
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity.
Kent BD; Ryan S; McNicholas WT
Respir Physiol Neurobiol; 2011 Sep; 178(3):475-81. PubMed ID: 21439407
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
Ryan S; Taylor CT; McNicholas WT
Thorax; 2009 Jul; 64(7):631-6. PubMed ID: 19561283
[TBL] [Abstract][Full Text] [Related]
4. An update on obstructive sleep apnea and the metabolic syndrome.
Lam JC; Ip MS
Curr Opin Pulm Med; 2007 Nov; 13(6):484-9. PubMed ID: 17901753
[TBL] [Abstract][Full Text] [Related]
5. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea.
Jelic S; Le Jemtel TH
Trends Cardiovasc Med; 2008 Oct; 18(7):253-60. PubMed ID: 19232954
[TBL] [Abstract][Full Text] [Related]
6. Hypertension in obstructive sleep apnea: risk and therapy.
Das AM; Khayat R
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):619-26. PubMed ID: 19505277
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant nutrient intake and supplements as potential moderators of cognitive decline and cardiovascular disease in obstructive sleep apnea.
Baldwin CM; Bootzin RR; Schwenke DC; Quan SF
Sleep Med Rev; 2005 Dec; 9(6):459-76. PubMed ID: 16242980
[TBL] [Abstract][Full Text] [Related]
8. [Obstructive sleep apnea syndrome and cardiovascular diseases].
Bentivoglio M; Bergamini E; Fabbri M; Andreoli C; Bartolini C; Cosmi D; Capasso V; Bottini P; Ambrosio G
G Ital Cardiol (Rome); 2008 Jul; 9(7):472-81. PubMed ID: 18678213
[TBL] [Abstract][Full Text] [Related]
9. Obstructive sleep apnea hypopnea syndrome: a proinflammatory disorder.
Han F
Chin Med J (Engl); 2007 Sep; 120(17):1475-6. PubMed ID: 17908451
[No Abstract] [Full Text] [Related]
10. Hypertension and obstructive sleep apnoea syndrome: current perspectives.
Baguet JP; Barone-Rochette G; Pépin JL
J Hum Hypertens; 2009 Jul; 23(7):431-43. PubMed ID: 19129854
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
Pashkow FJ; Watumull DG; Campbell CL
Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
[TBL] [Abstract][Full Text] [Related]
12. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
[TBL] [Abstract][Full Text] [Related]
13. The role of adrenomedullin in obstructive sleep apnea.
Minoguchi K; Adachi M
Hypertens Res; 2007 Nov; 30(11):1007-8. PubMed ID: 18250545
[No Abstract] [Full Text] [Related]
14. Pediatric sleep apnea: early onset of the 'syndrome'?
Spicuzza L; Leonardi S; La Rosa M
Sleep Med Rev; 2009 Apr; 13(2):111-22. PubMed ID: 19058983
[TBL] [Abstract][Full Text] [Related]
15. [Obstructive sleep apnea syndrome and cardiovascular consequences: which complementary studies and monitoring?].
d'Ortho MP
Rev Pneumol Clin; 2009 Aug; 65(4):248-53. PubMed ID: 19789051
[TBL] [Abstract][Full Text] [Related]
16. Obesity and obstructive sleep apnea-hypopnea syndrome.
de Sousa AG; Cercato C; Mancini MC; Halpern A
Obes Rev; 2008 Jul; 9(4):340-54. PubMed ID: 18363635
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular aspects in obstructive sleep apnea syndrome--molecular issues, hypoxia and cytokine profiles.
Lavie L; Polotsky V
Respiration; 2009; 78(4):361-70. PubMed ID: 19786735
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of cardiovascular damage in obstructive sleep apnea].
Torre-Bouscoulet L; Castorena-Maldonado A; Sada-Ovalle I; Meza-Vargas MS
Rev Invest Clin; 2008; 60(6):502-16. PubMed ID: 19378837
[TBL] [Abstract][Full Text] [Related]
19. Obstructive sleep apnea syndrome is a systemic disease. Current evidence.
Zamarron C; García Paz V; Riveiro A
Eur J Intern Med; 2008 Oct; 19(6):390-8. PubMed ID: 18848171
[TBL] [Abstract][Full Text] [Related]
20. Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome.
Carpagnano GE; Spanevello A; Sabato R; Depalo A; Turchiarelli V; Foschino Barbaro MP
Transl Res; 2008 Jan; 151(1):45-50. PubMed ID: 18061127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
